These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 1505023)

  • 1. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter.
    Liu Y; Peter D; Roghani A; Schuldiner S; Privé GG; Eisenberg D; Brecha N; Edwards RH
    Cell; 1992 Aug; 70(4):539-51. PubMed ID: 1505023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular cloning and expression of a human synaptic vesicle amine transporter that suppresses MPP+ toxicity.
    Liu L; Xu W; Harrington KA; Emson PC
    Brain Res Mol Brain Res; 1994 Aug; 25(1-2):90-6. PubMed ID: 7984057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology of a vesicular amine transporter to a gene conferring resistance to 1-methyl-4-phenylpyridinium.
    Stern-Bach Y; Keen JN; Bejerano M; Steiner-Mordoch S; Wallach M; Findlay JB; Schuldiner S
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9730-3. PubMed ID: 1357668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.
    Pifl C; Giros B; Caron MG
    J Neurosci; 1993 Oct; 13(10):4246-53. PubMed ID: 8410185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    Staal RG; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Staal RG; Yang JM; Hait WN; Sonsalla PK
    Brain Res; 2001 Aug; 910(1-2):116-25. PubMed ID: 11489261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transport of neurotransmitters into synaptic vesicles.
    Peter D; Liu Y; Brecha N; Edwards RH
    Prog Brain Res; 1995; 105():273-81. PubMed ID: 7568887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxin 1-methyl-4-phenylpyridinium is a substrate for the canalicular organic cation/H+ exchanger.
    Moseley RH; Zugger LJ; Van Dyke RW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):34-40. PubMed ID: 9103477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reserpine binding to a vesicular amine transporter expressed in Chinese hamster ovary fibroblasts.
    Schuldiner S; Liu Y; Edwards RH
    J Biol Chem; 1993 Jan; 268(1):29-34. PubMed ID: 8416935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells.
    Chen CX; Huang SY; Zhang L; Liu YJ
    Neurobiol Dis; 2005 Aug; 19(3):419-26. PubMed ID: 16023584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of the neurotoxin, 4-methylphenylpyridinium, into chromaffin granules and synaptic vesicles: a proton gradient drives its uptake through monoamine transporter.
    Moriyama Y; Amakatsu K; Futai M
    Arch Biochem Biophys; 1993 Sep; 305(2):271-7. PubMed ID: 8373164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive sequence divergence between the human and rat brain vesicular monoamine transporter: possible molecular basis for species differences in the susceptibility to MPP+.
    Lesch KP; Gross J; Wolozin BL; Murphy DL; Riederer P
    J Neural Transm Gen Sect; 1993; 93(1):75-82. PubMed ID: 8373557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters.
    Yelin R; Schuldiner S
    FEBS Lett; 1995 Dec; 377(2):201-7. PubMed ID: 8543051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors.
    Peter D; Jimenez J; Liu Y; Kim J; Edwards RH
    J Biol Chem; 1994 Mar; 269(10):7231-7. PubMed ID: 8125935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression cloning of a reserpine-sensitive vesicular monoamine transporter.
    Erickson JD; Eiden LE; Hoffman BJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10993-7. PubMed ID: 1438304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and regulation of the bovine vesicular monoamine transporter gene.
    Krejci E; Gasnier B; Botton D; Isambert MF; Sagné C; Gagnon J; Massoulié J; Henry JP
    FEBS Lett; 1993 Nov; 335(1):27-32. PubMed ID: 7902299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules.
    Howell M; Shirvan A; Stern-Bach Y; Steiner-Mordoch S; Strasser JE; Dean GE; Schuldiner S
    FEBS Lett; 1994 Jan; 338(1):16-22. PubMed ID: 8307150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vesicular transport proteins in synaptic transmission and neural degeneration.
    Liu Y; Edwards RH
    Annu Rev Neurosci; 1997; 20():125-56. PubMed ID: 9056710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells.
    Liu Y; Schweitzer ES; Nirenberg MJ; Pickel VM; Evans CJ; Edwards RH
    J Cell Biol; 1994 Dec; 127(5):1419-33. PubMed ID: 7962100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.